Groups | General | With Sch-PAH | Without Sch-PAH | p-value |
---|---|---|---|---|
Samples | 68 | 34 | 34 | - |
Age (mean ± sd) | 49.3 ± 12.9 | 49.8 ± 13.2 | 49.8 ± 12.8 | 0.759a |
Sex: Male | 24 (35.3%) | 11 (32.3%) | 13 (38.2%) | 0.612 |
Clinical form | Â | Â | Â | Â |
  Hepatosplenic | 64 (94.1%) | 30 (88.2%) | 34 (100%) | 0.039c |
  Hepatointestinal | 04 (5.9%) | 04 (17.8%) | 00 (-) |  |
Periportal fibrosis | Â | Â | Â | Â |
  Dx | 24 (35.3%) | 13 (38.2%) | 11 (32.3%) |  |
  E | 37 (54.4%) | 18 (52.9%) | 19 (55.9%) | 0.674c |
  F | 07 (10.3%) | 03 (8.9%) | 04 (11.8%) | 0.685 |
TGF-β1 pg/ml (median – P25; P75) | 19442.2 (11070.4; 30097.2) | 22496.9 (15936.7; 32087.8) | 13629.9 (10192.2; 22193.8) | 0.006b |
IL-13 pg/ml (median – P25; P75) | 152.3 (100.2; 165.0) | 152.3 (103.7; 177.8) | 131.8 (100.2; 162.5) | 0.177b |
Portal vein diameter cm | 1.15 ± 0.33 | 1.09 ± 0.37 | 1.23 ± 0.25 | 0.085a |
Spleen diameter cm | 14.5 ± 3.3 | 12.7 ± 2.17 | 16.4 ± 3.3 | 0.000a |